cannabiswire2d
Rescheduling Won’t Clarify FDA’s Oversight of Cannabis Products, CRS Report Says
The report for Congress specifies that lawmakers would need to help shape which products are allowed, and in what form.
pulmonologyadvisor2d
FDA Alert: Pulmonology Drug Approvals and Recalls, Medical Device Updates
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
dermatologyadvisor2d
FDA Accepts KalVista’s NDA for Sebetralstat to Treat HAE
KONFIDENT phase 3 trial results demonstrated significantly faster symptom relief with sebetralstat compared to placebo.
JD Supra3d
Test Anxiety: FDA Issues Warning Letters to Test Laboratories
The Food and Drug Administration (FDA) recently issued warning letters to two third-party nonclinical testing laboratories.
gastroenterologyadvisor3d
FDA Limits Authorized Use of COVID-19 PrEP Therapy Pemgarda
The FDA has revised the EUA for Pemgarda (pemivibart), authorized for the preexposure prophylaxis of COVID-19.
Endocrinology Advisor3d
FDA Clears Epitomee, an Ingestible Device for Weight Management
The FDA has cleared the Epitomee capsule to support weight management in adults with a body mass index of 25 to 40kg/m2.